Bruce Greenberg | Interim Chief Financial Officer |
Todd Brady | President and Chief Executive Officer |
Marc Goodman | SVB Securities |
Justin Kim | Oppenheimer |
Yale Jen | Laidlaw & Co. |
Catherine Novack | Jones Research |
Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therapeutics Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. I would now like to hand over the conference to the company's Interim Chief Financial Officer, Mr. Bruce Greenberg.